secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nutex Health Inc. (NUTX)
CIK:        0001479681
Form:       8-K
Filed at:   2024-04-11T23:59:59+00:00
Accession:  0001558370-24-004950
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nutex Health effects 1-for-15 reverse stock split; trading on split-adjusted basis from April 10
--------------------------------------------------------------------------------

- Board approved 1-for-15 reverse split effective April 9, 2024 after filing Certificate of Amendment with Delaware.
- No fractional shares issued; stockholders receive one whole share for any fractional interest.
- Authorized shares unchanged at 950 million; par value $0.001 per share; new CUSIP 67079U207.
- Common stock trades under symbol NUTX on Nasdaq beginning April 10, 2024 on post-split basis.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479681/000155837024004950/0001558370-24-004950-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479681/000155837024004950/nutx-20240409x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-004950

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer